Severe Thrombocytopenia Induced by Second Exposure to Trastuzumab Can Be Alleviated by Prolonging the Interval Between Treatments

Saved in:
Bibliographic Details
Published inClinical breast cancer Vol. 14; no. 2; pp. e69 - e72
Main Authors Zeng, Rui-chao, Dai, Xuan-xuan, Xie, Fei-yan, Chen, En-dong, Qu, Jin-miao, Hu, Xiao-qu
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2014
Subjects
Antibodies, Monoclonal, Humanized - therapeutic use
Antineoplastic Agents - therapeutic use
Breast carcinoma
Breast Neoplasms - drug therapy
Female
Hematology, Oncology and Palliative Medicine
Humans
Middle Aged
Obstetrics and Gynecology
Prognosis
Thrombocytopenia
Thrombocytopenia - chemically induced
Thrombocytopenia - prevention & control
Time Factors
Trastuzumab
Thrombocytopenia
Breast carcinoma
Trastuzumab
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1526-8209
1938-0666
DOI:10.1016/j.clbc.2013.11.004